Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02996266 · ClinicalTrials.gov registry record · NA
Impact of Fever Prevention in Brain Injured Patients
A NA study, sponsored by C. R. Bard.
- Terminated
- Registry status
- NA
- Development phase
- 686
- Enrollment target
NCT02996266 is a NA study that was terminated before completion, run by C. R. Bard. The registered enrollment target is 686 participants.
The verdict
NCT02996266, a NA study, was terminated before completion, sponsored by C. R. Bard.
- TERMINATED
- Registry status
- NA
- Development phase
- 686 participants
- Enrollment target
Study Summary
This study will assess the impact of fever prevention on fever burden and short- and long-term neurologic outcomes in brain injured patients. Half of the subjects will undergo fever prevention using a targeted temperature management system and half of the subjects will be treated for fever should it develop.
Interventions
- OTHER Standard Care
- DEVICE Targeted Temperature Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 686 participants |
| Start Date | 2017-01 |
| Est. Completion | 2022-05-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02996266
The ClinicalTrials.gov registry entry for NCT02996266 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 686 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.
NCT02996266 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02996266 about?
NCT02996266 is a clinical study titled "Impact of Fever Prevention in Brain Injured Patients". This study will assess the impact of fever prevention on fever burden and short- and long-term neurologic outcomes in brain injured patients. Half of the subjects will undergo fever prevention using a targeted temperature management system and half of the subjects will be treated for fever should it...
What is the current status of trial NCT02996266?
This trial is currently terminated. It is a NA study. The enrollment target is 686 participants. The study started on 2017-01. Estimated completion is 2022-05-12.
What interventions are being tested in trial NCT02996266?
The interventions under investigation include: Standard Care (OTHER), Targeted Temperature Management (DEVICE).
Who is sponsoring clinical trial NCT02996266?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.